Botanical species · safety record

Rhaponticum carthamoides

The EFSA Compendium of Botanicals holds 9 constituent measurements for Rhaponticum carthamoides. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Rhaponticum carthamoides (Willd.) Iljin

9Constituent measurements

0Safety records

4Cited sources

24Licensed products (Canada)

Also recorded as

Stemmacantha carthamoides (Willd.) Dittrich
Leuzea carthamoides (Willd.) DC.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 24 licensed products naming Rhaponticum carthamoides as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Root
Root and Rhizome

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Cynaropicrin	Leaves	Super-critical gas extraction	0.046 Percent	HPLC with standard detection methods	Resolve DOI
Esculetin	Leaves	Solvent extraction	≤ 416.8 Microgram/100 gram	HPLC-UV	Resolve DOI
Esculetin	Leaves	Solvent extraction	≥ 17.2 Microgram/100 gram	HPLC-UV	Resolve DOI
Lignans	Fruit unspecified	Solvent extraction	—	GC-MS	Resolve DOI
Scopoletin	Leaves	Solvent extraction	≥ 16.7 Microgram/100 gram	HPLC-UV	Resolve DOI
Scopoletin	Leaves	Solvent extraction	≤ 179.6 Microgram/100 gram	HPLC-UV	Resolve DOI
Umbelliferone	Leaves	Solvent extraction	≥ 1.5 Microgram/100 gram	HPLC-UV	Resolve DOI
Umbelliferone	Leaves	Solvent extraction	≤ 133.5 Microgram/100 gram	HPLC-UV	Resolve DOI
Eleutheroside b	Roots and other underground parts	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Bajerova, Petra., Adam, Martin., Bajer, Tomas., Ventura, Karel. Comparison of various techniques for the extraction and determination of antioxidants in plants. JOURNAL OF SEPARATION SCIENCE, 2014, vol. 37, no. 7, p. 835-844. DOI
Solyomvary, Anna., Mervai, Zsolt., Molnar-Perl, Ibolya., Boldizsar, Imre. Specific hydrolysis and accumulation of antiproliferative lignans in the fruit of Leuzea carthamoides (Willd.) DC.. NATURAL PRODUCT RESEARCH, 2014, vol. 28, no. 10, p. 732-739. DOI
Sovova, Helena., Opletal, Lubomir., Sajfrtova, Marie., Bartlova, Milena. Supercritical fluid extraction of cynaropicrin and 20-hydroxyecdysone from Leuzea carthamoides DC. JOURNAL OF SEPARATION SCIENCE, 2008, vol. 31, no. 8, p. 1387-1392. DOI
Huang, Min-fang., Li, Ning., Ni, Hui., Jia, Xiao-guang., Li, Xian. Constituents from root of Rhaponticum carthamoides (Willd.)Iljin. Shenyang yaoke daxue xuebao, 2009, p. 527-529.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature